Assembly Biosciences Inc Cash Flow Reinvestment Rate

Latest as of December 2025: 1.49x

Assembly Biosciences Inc cash flow reinvestment rate. Assembly Biosciences Inc (ASMB) has a Cash Flow Reinvestment Rate of 1.49x as of December 2025, reinvesting $21.27 Million (capex $24.00K plus investments $21.25 Million) from operating cash flow of $14.24 Million. Explore ASMB operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

1.49x
(Capex + Investments) / Operating CF

Total Reinvested

$21.27 Million
Capex + Investments

Operating Cash Flow

$14.24 Million
USD

Capital Expenditures

$24.00K
USD

Cash Flow Reinvestment Rate of Assembly Biosciences Inc (2017–2023)

Cash flow reinvestment rate of Assembly Biosciences Inc from 2017 to 2023. Historical reinvestment intensity for Assembly Biosciences Inc across 2 annual periods. Explore capital reinvestment ratio of Assembly Biosciences Inc to see what proportion of operating cash flow is directed to capital expenditures.

Assembly Biosciences Inc Cash Flow Reinvestment Rate by Year (2017–2023)

Assembly Biosciences Inc cash flow reinvestment rate by year from 2017 to 2023. Year-by-year capital reinvestment analysis for Assembly Biosciences Inc. For the full cash flow conversion analysis, see ASMB cash flow metrics.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2023 1.64x $37.33 Million $22.74 Million $255.00K ▼ -80.5%
2017 8.41x $15.64 Million $1.86 Million $864.56K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow